Cardiac cell sheet engineering for regenerative medicine and tissue modeling

Area of Science:

• Cardiovascular Research
• Regenerative Medicine
• Stem Cell Biology

Background:

• Cardiac tissue engineering is crucial for developing treatments for heart disease.
• Human induced pluripotent stem cell-derived cardiomyocytes (hiPSC-CMs) offer a promising source for cardiac tissue construction.
• Cell sheet engineering provides a method for fabricating three-dimensional cardiac tissues.

Purpose of the Study:

• To fabricate functional human cardiac tissue using mass-produced hiPSC-CMs and cell sheet engineering.
• To develop regenerative medicine strategies and tissue models for heart disease research.
• To establish indispensable technologies for cardiac tissue fabrication and functional evaluation.

Main Methods:

• Mass production of human induced pluripotent stem cell-derived cardiomyocytes (hiPSC-CMs).
• Application of cell sheet engineering for cardiac tissue fabrication.
• Evaluation of contractile and electrophysiological functions of the engineered cardiac tissue.

Main Results:

• Successful fabrication of human cardiac tissue using hiPSC-CMs and cell sheet engineering.
• Development of technologies for assessing cardiac tissue contractile and electrophysiological functions.
• Demonstrated potential for functional improvement of bioengineered human cardiac tissue.

Conclusions:

• Engineered human cardiac tissue holds significant promise for heart disease research and regenerative medicine.
• Advancements in hiPSC-CM production and cell sheet engineering are key to creating functional cardiac constructs.
• Robust functional evaluation technologies are essential for the clinical translation of bioengineered cardiac tissues.